Showing results (91-100 of 152) with videos related to
Sort By:
Pageof 16
Radiation Research|October 7, 2000
Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cellsB A Woynarowska, K Roberts, J M Woynarowski, et al.In Vitro Cellular & Developmental Biology. Animal|August 26, 1999
Selective cytotoxicity of 3-amino-L-tyrosine correlates with peroxidase activityJ G Bruno, T S Herman, V L Cano, et al.International Journal of Radiation Oncology, Biology, Physics|April 30, 1993
Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprussideB A Teicher, S A Holden, D Northey, et al.Journal of the National Cancer Institute|February 5, 1992
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcomaS A Holden, B A Teicher, G Ara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes studyC J Beard, K J Propert, P P Rieker, et al.International Journal of Cancer|June 19, 1991
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivoJ Tanaka, B A Teicher, T S Herman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Combination of etanidazole with cyclophosphamide and platinum complexesB A Teicher, T S Herman, L Shulman, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1988
Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignanciesT S Herman, B A Teicher, M Jochelson, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Influence of scheduling on two-drug combinations of alkylating agents in vivoB A Teicher, S A Holden, S M Jones, et al.Anticancer Research|September 1, 1993
A carbonic anhydrase inhibitor as a potential modulator of cancer therapiesB A Teicher, S D Liu, J T Liu, et al.Pageof 16